Splet27. jun. 2024 · PDL BioPharma Inc. (NASDAQ: PDLI) investors should pay attention to a decrease in support from the world's most elite money managers in recent months. PDLI was in 14 hedge funds'... SpletPDL BioPharma Inc (PDLI) NASDAQ Add to Watchlist 2.470 0.000 ( 0.00 %) 30/12 - Closed. Currency in USD ( Disclaimer) Volume: 0 Day's Range: 2.390 - 2.780 52 wk Range: 2.390 - 2.780 Trading near...
The Daily Production Report Explained (with FREE production …
SpletPDL BioPharma, Inc. (NASDAQ:PDLI) major shareholder Silver Point Capital L.P. bought 640,000 shares of the firm’s stock in a transaction that occurred on Monday, December 14th. The stock was purchased at an average cost of $2.62 per share, with a total value of $1,676,800.00. The acquisition was disclosed in a filing with the Securities & […] SpletOn May 13, 2024, the Company made a cash distribution of $1.00/share to its stockholders of record as of January 4, 2024. As announced on December 8, 2024, the voluntary … The Investor Relations website contains information about PDL BioPharma, Inc.'s … PDL does not anticipate making any distributions to stockholders before the … Christopher Stone CEO, General Counsel and Secretary. Christopher Stone, our … The Investor Relations website contains information about PDL BioPharma, Inc.'s … Investor Updates PDL BioPharma, Inc. You have requested to receive email updates from PDL BioPharma, Inc. … foster grant crystal vision
PDL BioPharma, Inc. (PDLI) Jumps: Stock Rises 8.2% - Yahoo …
SpletInside Pdl Biopharma, Inc.'s 10-K Annual Report: Financial - Expense Highlight. Financial - Expense Highlight. Our future capital requirements primarily relate to the costs to wind down the Company, including expenses to manage the remaining business, such as salaries and other employee compensation, rental payments, insurance, and taxes ... SpletPC-TEL INC PCTI. 中文簡稱:PC-Tel Inc Phelps Dodge Corp PD. 中文簡稱:菲道 PRIDE INTERNATL INC PDE; Placer Dome Inc PDG. 中文簡稱:普頓 PDL BIOPHARMA INC PDLI. SpletPDL BioPharma (NASDAQ: PDLI) was a fully integrated biopharmaceutical company that underwent a significant repositioning that began in 2007 and resulted in the sale of its commercial and ... foster grant eastwood